China clears Pfizer’s GLP-1 weight-loss drug Xianweiying
SHANGHAI, March 6— Pfizer said on Friday that China has approved its GLP-1 treatment Xianweiying for long-term weight management in
Read More
Factual Version of a Story
#Ecnoglutide